Christa R. Bleyleben – Senior Partner

Christa Bleyleben is the Founder and Managing Partner of MassGlobal Partners LLC, an international strategy and tactical advisory firm, helping innovative companies to internationalize their businesses. Christa brings more than 25 years of experience in building global relationships – working in executive management roles in both the public as well as private sectors. In her prior career, Christa was Executive Director of the Massachusetts Office of International Trade and Investment (MOITI), and President of the Massachusetts International Trade Council (MITCI). Previously, Christa was a Managing Director at Banc of America Securities LLC, with overall responsibility to manage the bank’s relationships with the world’s top 250 financial institutions. Christa serves on the management team of BostonLanding.US and BostonDigital.us and is an advisor to ‘Global Emerging LLC’, which offers market entry and finance platforms for American and European companies wishing to enter the Greater China markets. She is a coach and mentor to start-up companies and collaborates with MIT’s entrepreneurship training ‘eTeams ‘ program. Christa holds an MBA from the Vienna University of Economics & Business and attended executive programs at Kellogg School of Management in Chicago & Tuck School of Business in Dartmouth, New Hampshire.

Robert Gottlieb – Senior Partner

Robert Gottlieb is a strategic advisor and facilitator emerging companies establishing their corporate identities and positioning them for financing and partnering. He has a strong track record working with wellover150 companies and organizations across multiple industry sectors,rangingfromstart-upstomulti-nationals to academic institutions. Robert co-founded FeinsteinKean Healthcare(now a division of Ogilvy Public Relations Worldwide), a Massachusetts-based communications and business-consulting firm,focused on life sciences. In addition to his role at MassGlobal Partners, Robert is Principal at RMG Associates LLC and serves on the board of directors of the industry association MassBio. He also participates as a mentor in MIT’s Venture Mentoring Service and the Boston UniversityBusiness School’s Health Sector mentoring program. Earlier in his career, Robert directed corporate communications at Biogen Inc. and served as Executive Editor at “F-D-C” Reports “The Pink Sheet.” Robert holds a BA degree from Trinity College, Connecticut.

Nancy J. Levy, Ph.D. – Senior Partner

Nancy Levy, Ph.D., is a strategy and tactical business development executive, facilitating growth of small and medium sized, international companies. She offers in-depth, hands-on consulting to define business and market strategies and their go-to-market implementation. In addition to her role with MassGlobal Partners, Nancy is the Managing Partner of BioHealth Management LLC, and serves as the Managing Partnerof BostonLanding.US. Nancyis on numerous boards, including Acceleration Pharmaceuticals, Propel Careers,and SOM Biotech in Barcelona, Spain and is a member of the Newton-Wellesley Hospital board of overseers. She is an active mentor at the Venture Mentor Service (VMS) at MIT, and a member of the VMS Outreach team, training other organizations in mentoring & coaching strategies. She is an adjunct professor at the Boston University School of Management and has been on the faculty at Harvard Medical School, where she also did her fellowship. Prior roles include senior positions at Millennium Pharmaceuticals, Immunetics and Genzyme. Nancy earned her Ph.D. from the University of Chicago.

Mark Trusheim
Founder and President, Co-Bio Consulting

Mark Trusheim is founder and President of Co-Bio Consulting, LLC as well as Executive in Residence and Visiting Scientist at the MIT Sloan School of Management and a former Special Government Employee for the FDA's Office of the Commissioner. Mr. Trusheim is a former member of the Massachusetts Biotechnology Council's Board of Directors, which helps its over 500 members succeed in the state. In 2004 he served as the Interim President of the MBC, leading its successful legislative agenda. As an entrepreneur, he founded and was the President and CEO of Cantata Laboratories. Cantata marketed clinical diagnostics and pharmaceutical biomarker services based on its biochemical profiling platform. Prior to Cantata, Mr. Trusheim spent over 10 years at Monsanto/Pharmacia, culminating his career there as Co-President and Chief Operating Officer of Cereon Genomics, LLC. Located in Cambridge, Massachusetts, Cereon was created in 1997 by Monsanto as part of a $500M collaboration with Millennium Pharmaceuticals. Prior to his position at Cereon, Mr. Trusheimwas responsible for Monsanto's external genomics relationships and held roles of Vice President in the Health & Wellness Sector, Marketing Director in Searle Pharmaceutical and Director in Agriculture Division Strategy. Mr. Trusheim spent the first half of his career in the high tech industry working at both Wang Laboratories in computer hardware and the start-up Kenan Systems Corporation in software services which exited to Lucent for >$1 billion. He holds degrees in Chemistry from Stanford University and Management from MIT.

Tomasz H. Zastawny, PhD, DSc, MSc.
Founder and President, Executive Clinical Research Consulting, LLC

Dr. Zastawny is a clinical research professional and scientist with more than 20 years of proven achievements in international clinical research and corporate business management. As a strategic business partner, his expertise is in providing strategic clinical research counsel to drug development executives and teams of privately held and publicly traded life sciences companies. Prior to founding Executive Clinical Research Consulting, Dr. Zastawny was a Clinical Operations Director at Infinity Pharmaceuticals. Previously he was the Clinical Projects Director at Pro-Pharmaceuticals, Director of Operations at PRA International. As the Chairman of the Board for PRA's Central and Eastern European subsidiary he contributed significantly to company growth in this region. Currently he is on the Supervisory Board of KCR S.A. a leading European R&D organization based in Poland. He has published more than 70 peer-reviewed articles, editorials, book chapters and reviews on scientific symposia in international clinical research and mechanisms of carcinogenesis, and cancer therapy. Dr. Zastawny received his educational training at the interface of business and medical research. He has post graduate degrees in Business Management from Management and Banking School in Poznan, Poland as well as DSc in Biochemistry from the Polish Academy of Science, PhD in Medical Sciences from University of Medical Sciences in Bydgoszcz, and MS from University of Lodz. He did a doctoral fellowship at National Institute of Standards and Technology (USA) and Leiden University Medical Center (The Netherlands).